Kentaro Machida

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Allergic Rhinitis

Chronic Obstructive Pulmonary Disease

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Asako Hamu-Tanoue, Koichi Takagi, Yoshitaka Taketomi, Yoshimi Miki, Yasumasa Nishito, Kuniyuki Kano, Junken Aoki, Takahiro Matsuyama, Kiyotaka Kondo, Yoichi Dotake, Hiromi Matsuyama, Kentaro Machida, Makoto Murakami, Hiromasa Inoue
Group III secreted phospholipase A 2 -driven lysophospholipid pathway protects against allergic asthma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Asako Hamu-Tanoue, Koichi Takagi, Yoshitaka Taketomi, Yoshimi Miki, Yasumasa Nishito, Kuniyuki Kano, Junken Aoki, Takahiro Matsuyama, Kiyotaka Kondo, Yoichi Dotake, Hiromi Matsuyama, Kentaro Machida, Makoto Murakami, Hiromasa Inoue
Group III secreted phospholipase A 2 -driven lysophospholipid pathway protects against allergic asthma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Takahiro Matsuyama, Brittany Marie Salter, Nahal Emami Fard, Kentaro Machida, Roma Sehmi
TNF Superfamily and ILC2 Activation in Asthma. Biomolecules 14 (3) (2024)
Takahiro Matsuyama, Brittany Marie Salter, Nahal Emami Fard, Kentaro Machida, Roma Sehmi
TNF Superfamily and ILC2 Activation in Asthma. Biomolecules 14 (3) (2024)
Asako Hamu-Tanoue, Koichi Takagi, Yoshitaka Taketomi, Yoshimi Miki, Yasumasa Nishito, Kuniyuki Kano, Junken Aoki, Takahiro Matsuyama, Kiyotaka Kondo, Yoichi Dotake, Hiromi Matsuyama, Kentaro Machida, Makoto Murakami, Hiromasa Inoue
Group III secreted phospholipase A 2 -driven lysophospholipid pathway protects against allergic asthma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Takahiro Matsuyama, Brittany Marie Salter, Nahal Emami Fard, Kentaro Machida, Roma Sehmi
TNF Superfamily and ILC2 Activation in Asthma. Biomolecules 14 (3) (2024)
Takahiro Matsuyama, Kentaro Machida, Keiko Mizuno, Hiromi Matsuyama, Yoichi Dotake, Masahiro Shinmura, Koichi Takagi, Hiromasa Inoue
The Functional Role of Group 2 Innate Lymphoid Cells in Asthma. Biomolecules 13 (6) (2023)
Takahiro Matsuyama, Kentaro Machida, Keiko Mizuno, Hiromi Matsuyama, Yoichi Dotake, Masahiro Shinmura, Koichi Takagi, Hiromasa Inoue
The Functional Role of Group 2 Innate Lymphoid Cells in Asthma. Biomolecules 13 (6) (2023)
Takahiro Matsuyama, Kentaro Machida, Keiko Mizuno, Hiromi Matsuyama, Yoichi Dotake, Masahiro Shinmura, Koichi Takagi, Hiromasa Inoue
The Functional Role of Group 2 Innate Lymphoid Cells in Asthma. Biomolecules 13 (6) (2023)
Kentaro Machida, Tomotaka Kawayama, Masaharu Kinoshita, Masakazu Ichinose, Tohru Tsuda, Shohei Takata, Hiroshi Koto, Makoto Yoshida, Yoshinori Ashihara, Masaru Kawashima, Hideaki Suna, Hiromasa Inoue
Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial. International journal of chronic obstructive pulmonary disease 14 (2019)